Frederick Financial Consultants LLC Invests $271,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Frederick Financial Consultants LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 536 shares of the healthcare conglomerate’s stock, valued at approximately $271,000.

A number of other institutional investors have also made changes to their positions in the stock. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $341,000. Principal Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the period. M&T Bank Corp increased its stake in UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares during the period. McIlrath & Eck LLC increased its stake in shares of UnitedHealth Group by 8.2% during the third quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate’s stock worth $371,000 after acquiring an additional 48 shares during the period. Finally, SOA Wealth Advisors LLC. increased its position in UnitedHealth Group by 3.7% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate’s stock worth $746,000 after purchasing an additional 46 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 22.0 %

NYSE UNH opened at $456.10 on Friday. The company’s fifty day moving average price is $514.51 and its two-hundred day moving average price is $541.53. UnitedHealth Group Incorporated has a 12 month low of $438.50 and a 12 month high of $630.73. The company has a market capitalization of $417.20 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business earned $6.91 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.84%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Erste Group Bank upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Wednesday. Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Truist Financial lifted their price objective on UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research report on Friday, April 11th. Finally, Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Twenty-one investment analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $632.85.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.